Gene · 7372
Papers1,811
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,811
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis. | J Physiol Biochem | 2022 | 35674867 | PubTator, text mining | PubMed |
| A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses. | Viruses | 2022 | 35632670 | PubTator, text mining | PubMed |
| 3,3'-Diindolylmethane Enhances Fluorouracil Sensitivity via Inhibition of Pyrimidine Metabolism in Colorectal Cancer. | Metabolites | 2022 | 35629914 | PubTator, text mining | PubMed |
| Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. | Sci Rep | 2022 | 35595817 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies rare genetic variants associated with human plasma metabolites. | Am J Hum Genet | 2022 | 35568032 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. | Sci Adv | 2022 | 35559673 | PubTator, text mining | PubMed |
| Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. | Cell Rep | 2022 | 35545034 | PubTator, text mining | PubMed |
| EGLN1 induces tumorigenesis and radioresistance in nasopharyngeal carcinoma by promoting ubiquitination of p53 in a hydroxylase-dependent manner. | J Cancer | 2022 | 35517429 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. | J Hematol Oncol | 2022 | 35477416 | PubTator, text mining | PubMed |
| Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases. | Molecules | 2022 | 35458666 | PubTator, text mining | PubMed |
| Engineering of Synthetic Transcriptional Switches in Yeast. | Life (Basel) | 2022 | 35455048 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| Recent Advances of Pyridinone in Medicinal Chemistry. | Front Chem | 2022 | 35402370 | PubTator, text mining | PubMed |
| Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models. | Front Oncol | 2022 | 35372014 | PubTator, text mining | PubMed |
| Case Report: A Novel Missense Mutation c.517G>C in the UMPS Gene Associated With Mild Orotic Aciduria. | Front Neurol | 2022 | 35356460 | PubTator, text mining | PubMed |
| Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. | Signal Transduct Target Ther | 2022 | 35351858 | PubTator, text mining | PubMed |
| Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response. | Commun Biol | 2022 | 35347215 | PubTator, text mining | PubMed |
| Identification of the toxic 6mer seed consensus for human cancer cells. | Sci Rep | 2022 | 35332222 | PubTator, text mining | PubMed |
| Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase. | Front Cell Infect Microbiol | 2022 | 35310840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7372/papers?page=9